Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement.
By Vasilis Ntziachristos, A. G. Yodh, M. Schnall, B. Chance. Proceedings of the National Academy of Sciences of the United States of America, 2000
887 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/d7c230f935837acfdf3a6713860b5014ce430e17
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
- Vasilis Ntziachristos
- Ralph Weissleder
- Turgut Durduran
- C. Tung
- C. Bremer
- John V. Frangioni
- Umar Mahmood
- Simon Robert Arridge
In Radiology, Nuclear Medicine and Imaging
- Vasilis Ntziachristos
- Ralph Weissleder
- Turgut Durduran
- John V. Frangioni
- C. Bremer
- C. Tung
- Umar Mahmood
- Valery V. Tuchin
Citations in the corpus
- Recent advances in diffuse optical imaging (2005, methodology): “Ntziachristos et al (1998) built and tested a combined MR/optical imaging system and successfully used it to record optical and MR images from volunteers with a range of benign and malignant lesions (Ntziachristos et al 2000, 2002c).”
- Fluorescence molecular imaging. (2006, background): “Importantly, it has been shown that detection of exogenous agents is possible through the human breast in vivo (140, 141).”
- Near-infrared optical imaging of proteases in cancer. (2003, methodology): “The mice received no injection, injection of the cathepsin B-activatable probe, or injection of ICG, a fluorescent perfusion agent approved for human use.”
- Shedding light onto live molecular targets (2003, background): “Indeed it has become possible to image (and, importantly, to quantify) fluorochrome concentration”
- The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery (2011, background): “During the first 10 min, ICG was retained in the breast tumour tissue and provided contrast to the surrounding healthy tissue [81,82].”
- Diffuse Optics for Tissue Monitoring and Tomography (2010, background): “ICG has been demonstrated to enhance absorption of human breast cancer in vivo [335, 370, 371].”
- In vivo molecular target assessment of matrix metalloproteinase inhibition (2001, methodology): “In preliminary studies, a related technique (diffuse optical tomography) has already been used to image tricarbocyanine dye accumulation in human breast cancer”
- Scaling down imaging: molecular mapping of cancer in mice (2002, methodology): “This technique might also be extended to clinical us”
- A Review of Indocyanine Green Fluorescent Imaging in Surgery (2012, methodology): “(iii) combining ICG and other imaging modalities like visual, CT, MRI, and PET [263–266],”